Ireland
--:--IST
Recruiting Observational

Satisfaction and Recovery After Distal Radius Fracture

NCT05818241 · tracked via the Priya Life Science Sweden tracker
Phase
Observational
Started
2023-01-12
Last updated
2026-04-24

Condition(s) studied

Distal Radius Fracture

Investigational drug(s) / intervention(s)

Treatment of fracture by forearm castSurgical treatment of fracture

Treatment of fracture by forearm cast: Patient that are not surgically treated for DRF

Surgical treatment of fracture: Patients that are surgically treated for DRF

Study summary

Distal radius fracture is the most common fracture in Sweden, but little is known about the patient's experience of pain and hand function during the first three months after the injury. This observational study will provide detailed information on a daily basis regarding pain, use of analgesic drugs, use of splints and hand function as measured weekly by a condition-specific questionnaire.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Unilateral distal radius fractures in patients without any other significant injuries regardless of ligament injuries and ulnar fractures. * Signed written consent Exclusion Criteria: * Compound injuries * Open fractures * Patients with post traumatic function deficits at any level in the affected arm prior to the distal radius fracture. * Patients with function deficits in the affected arm due to other medical conditions (e.g. Parkinsons disease, Rheumatoid Arthritis) * Reduced mental capacity (e.g. dementia, substance abuse)

Primary outcome measure(s)

  • Patient-reported hand function — Every week for three months
    Patient Rated Wrist Evaluation (PRWE) questionnaire

Trial sites (2)

FacilityCityRegionStatus
Sahlgrenska University Hospital, Department of Hand Therapy Mölndal Region Västra Götaland Recruiting
Alingsås Lasarett/ District Hospital Alingsås Sweden Not Yet Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05818241 on ClinicalTrials.gov ↗ ← All trials in Sweden